Novartis Investigative Site

Zurich, Switzerland 8091

0 studies enrolling now · 5 studies all time

What they study most

Acute Myelogenous Leukemia, Advanced Neuroendocrine Tumors of Pancreatic Origin, Hepatitis C, Liver Transplantation, Non-infectious Uveitis, Pulmonary Arterial Hypertension, Refractory Leukemia

Studies at this site

• Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) — Completed
• Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis — Stopped early
• Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors — Completed
• Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C — Completed
• Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH) — Stopped early